DEF 14C: CIMG Inc. Secures Stockholder Approval for $10 Million Convertible Note and Warrant Issuance to Comply with Nasdaq Listing Rule

Sentiment:

Information Statement 25 February 2025 4:10 PM

CIMG Inc. announces stockholder approval via written consent for the issuance of over 20% of its common stock related to a $10 million convertible note and warrant agreement, aimed at complying with Nasdaq Listing Rule 5635(d).

Capital raiseCIMG Inc. entered into a convertible note and warrant purchase agreement to raise $10,000,000.The company issued convertible promissory notes and warrants to non-U.S. investors.The notes bear interest at an annual rate of 7% and have a maturity date of one year from the issuance date.The notes can be converted into common stock at a price of $0.52 per share.The warrants can be exercised at a price of $0.39 per share to purchase up to 25,641,023 new shares of common stock.

Summary

CIMG Inc. has obtained stockholder approval through written consent for corporate actions related to a convertible note and warrant purchase agreement.
The approval pertains to the issuance of more than 20% of the company's common stock, necessary to comply with Nasdaq Listing Rule 5635(d).
This issuance is tied to a previously announced agreement dated December 12, 2024, to raise $10 million through convertible notes and warrants.
The company's majority shareholders approved the authorizations on February 10, 2025.
The Information Statement is being furnished to stockholders of record as of February 10, 2025.
The actions will be taken no earlier than the 20th day after the Information Statement is mailed to stockholders.
The company issued six Notes with an aggregate principal amount of $10,000,000 to six non-U.S. investors, following receipt of the respective purchase amounts.
In conjunction with the issuance of the Notes, the Company also issued Warrants to purchase an aggregate of 25,641,023 shares of common stock to these investors.

Sentiment

Score: 6

Explanation: The document is primarily informational, detailing a previously announced financing agreement and the required shareholder approval. While the financing is a positive development, the potential dilution is a concern, resulting in a neutral sentiment score.

Positives

The company has successfully obtained stockholder approval for the issuance of shares, removing a hurdle for the $10 million financing.
The financing provides CIMG Inc. with $10 million in capital through the issuance of convertible notes and warrants.

Negatives

The issuance of shares will dilute the ownership of existing stockholders.
The potential sale of shares issuable upon conversion of the notes and exercise of the warrants could negatively impact the company's stock price.

Risks

The issuance of a significant number of shares could lead to a decline in the company's stock price.
The dilutive effect of the new shares could negatively impact the voting power and economic rights of existing stockholders.
The company's stock price may experience greater volatility due to the potential issuance and sale of new shares.

Future Outlook

The company intends to proceed with the issuance of shares related to the convertible note and warrant agreement, subject to the 20-day waiting period after the Information Statement is mailed.

Management Comments

Jianshuang Wang, Chief Executive Officer and Director, stated that the Information Statement is being furnished to stockholders to inform them of the actions taken by written consent of the Majority Shareholders.

Industry Context

Many companies, especially smaller ones, use convertible notes and warrants to raise capital. This is a fairly standard method of financing, but it does come with the risk of dilution for existing shareholders.

Comparison to Industry Standards

The terms of the convertible note and warrant purchase agreement, including the interest rate, conversion price, and warrant exercise price, should be compared to similar financing agreements in the same industry to assess their competitiveness.
Comparable companies that have used similar financing structures could include other small-cap or micro-cap companies in the technology or related sectors.
The level of dilution resulting from the potential issuance of shares should be compared to industry benchmarks to determine if it is within an acceptable range.

Stakeholder Impact

Existing stockholders will experience dilution of their ownership.
The company will have access to additional capital to fund its operations.
The company's stock price may be affected by the potential issuance and sale of new shares.

Next Steps

The company will proceed with the issuance of shares no earlier than 20 days after the Information Statement is mailed.
The investors may convert the notes and exercise the warrants to acquire common stock.

Key Dates

Date	Description
December 12, 2024	Date of the convertible note and warrant purchase agreement.
January 16, 2025	First closing of the sale of the Notes and Warrants.
January 17, 2025	Second closing of the sale of the Notes and Warrants.
February 10, 2025	Record date for stockholders entitled to receive the Information Statement and date of majority shareholder approval.
February 24, 2025	Date of the Information Statement.
February 25, 2025	Date of the Notice of Written Consent of Stockholders.
February 27, 2025	Approximate date of first mailing of the Information Statement.

Keywords

CIMG Inc., Nasdaq Listing Rule 5635(d), convertible note, warrant, stock issuance, shareholder approval, dilution, financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.